Riverland's Catherine Haslag recognized as Outstanding Educator
Apr. 28—Catherine Haslag, a chemistry faculty member at Riverland Community College, was honored as an Outstanding Educator at the 2025 Minnesota State Board of Trustees Awards for Excellence in St. Paul on April 16.
Haslag was recognized for her innovative approach to teaching and her deep commitment to student success. She developed the first hybrid and fully online Introduction to Chemistry courses at Riverland, created a specialized chemistry course for nursing students, and launched the Science Fair Mentoring Project to connect K — 12 students with hands-on science experiences.
"Catherine exemplifies what it means to be a student-centered educator," said Kat Linaker, president of Riverland Community College. "Her dedication to teaching, innovation, and expanding access to STEM education reflects the very best of our mission and values."
The Board of Trustees Awards for Excellence acknowledge outstanding faculty across Minnesota State who demonstrate superior commitment to student learning and continuous improvement. Haslag's selection places her among the top educators systemwide.
"Catherine's work is transformative," said Heather Conley, vice president of Academics and Innovation. "She constantly explores new ways to engage students and extend the reach of science education across our institution."
Riverland celebrated Haslag's recognition and her contributions to academic excellence at an Awards and Recognition Ceremony held Friday at Riverland.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
a day ago
- Yahoo
Dr. Cockrell Joins Cutting-Edge Foot and Ankle Clinic in Nashville
Nashville-Davidson, June 05, 2025 (GLOBE NEWSWIRE) -- Nashville-Davidson, Tennessee - Cutting-Edge Foot and Ankle Clinic, led by podiatrists Dr. David Farnen and Dr. Yerusalem Lanier, along with nurse practitioner Morgan Hubble and physician assistant Rojin Abdullah, announced the addition of Dr. Gary Cockrell to its expanding and highly skilled medical staff. With convenient locations in Nashville and Brentwood, the practice continues its mission to provide advanced, comprehensive foot and ankle care to patients throughout the greater Middle Tennessee region. Dr. Cockrell brings more than 32 years of experience in podiatric medicine and surgery, making him one of the most seasoned specialists in the entire region. He is board-certified in foot and ankle surgery and holds diplomate status from the American Board of Foot and Ankle Surgery, underscoring his advanced surgical expertise. A native of Virginia, Dr. Cockrell earned a bachelor of science degree in animal science from Virginia Tech in 1979, with a minor in biology. He received his doctor of podiatric medicine degree from the California College of Podiatric Medicine in San Francisco in 1988. Following medical school, he completed a rigorous podiatric surgical residency at Baptist Memorial Hospital in Memphis-Georgetown, Tennessee, further honing his surgical skills and clinical expertise. Throughout his career, Dr. Cockrell has been recognized for clinical excellence and strong professional leadership. He received the Harry Casson Award for Outstanding Achievement, a notable honor in podiatry. He is also an active member of the American College of Foot and Ankle Surgeons and the American Podiatric Medical Association. Since 1995, Dr. Cockrell has served continuously on the Tennessee Podiatric Medical Association (TPMA) executive board, holding key roles including scientific chair, treasurer, secretary, vice president and president. He served two consecutive terms as TPMA president from 2001 to 2003, helping guide statewide initiatives to advance podiatric care and improve patient outcomes. In 2015, Dr. Cockrell became the first surgeon in Tennessee to use the Merete Medical Metafix PlantarMax tension-side fixation plate, a German-engineered device designed to improve surgical outcomes in bunion and plantar plate repairs. This innovative technology reflects his commitment to surgical advancements that promote better recovery and positive results. "We are thrilled to welcome Dr. Cockrell to our care team," said Dr. David Farnen, co-owner of Cutting-Edge Foot and Ankle Clinic. "His extensive experience, surgical innovation and patient-centered approach align perfectly with our mission to provide exceptional care to every patient." Dr. Cockrell is accepting new patients at both the Nashville and Brentwood clinics. He specializes in diabetic foot care, wound healing, sports injuries and advanced surgical interventions for complex foot and ankle conditions. His expertise ensures patients receive the highest standard of care for both routine and challenging foot health issues. Cutting-Edge Foot and Ankle Clinic is known for its use of advanced diagnostic tools and personalized podiatry treatment plans tailored to each patient's unique needs. The clinic offers a broad range of services, including minimally invasive procedures, regenerative medicine and custom orthotics. The collaborative team remains committed to delivering high-quality, patient-focused care in a welcoming, compassionate environment. Beyond treatment, the clinic emphasizes patient education about foot and ankle health, empowering individuals with knowledge about prevention, maintenance and treatment options. This holistic approach promotes improved mobility, reduces pain and improves overall quality of life. Whether addressing chronic conditions or acute injuries, the team guides patients every step of the way with expertise and compassion. For appointments or media inquiries, please contact: Cutting-Edge Foot And Ankle Clinic Nashville Location: 3443 Dickerson Pike, Suite 740 Nashville, TN 37207 Brentwood Location: 1001 Healthpark Drive, Suite 330 Brentwood, TN Phone: (615) 866-9639 Website: Hours: Monday-Friday, 8:00 AM - 5:00 PM About Cutting-Edge Foot And Ankle Clinic: Founded by Dr. David Farnen and Dr. Yerusalem Lanier, Cutting-Edge Foot And Ankle Clinic is a leading podiatric practice serving the Middle Tennessee area with locations in Nashville and Brentwood. The practice features a comprehensive team of healthcare providers including Morgan Hubble, MP and Rojin Abdullah, PA, delivering innovative and comprehensive foot and ankle care using the latest medical technologies and treatment approaches. ### For more information about Cutting Edge Foot And Ankle Clinic , contact the company here:Cutting Edge Foot And Ankle Clinic Dr. Yerusalem Lanier DPM615-866-9639yerulanier@ Dickerson Pike, Suite 740, Nashville, TN 37207 CONTACT: Dr. Yerusalem Lanier DPMError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Forbes
a day ago
- Forbes
2 Lies A Person With An Addiction Tells Themselves, By A Psychologist
Millions of people struggle with addiction every day. But some people struggle in silence because ... More these mental defenses keep them from accepting the truth. Living a life with addiction is like living in a prison. Many people in recovery from a long-term addiction will often speak of how freeing it feels not to have a substance controlling everything you do. Unfortunately, many people struggle to accept that they have a problem in the first place, delaying their recovery. A 2015 study published in Drug and Alcohol Dependence shows that denial can be the biggest barrier to sobriety or abstinence. Researchers highlight that despite how much addiction can lower your quality of life, it's common for people to deny having a problem — even though its effect on their lives is quite evident to everyone else. One reason for this is that many people view addiction through a stereotypical lens. Popular media has taught us to 'spot' a person with an addiction through the way they look, act or their lack of a functioning, socially acceptable lifestyle. According to an article by the National Institute on Drug Abuse, addiction is a 'chronic, relapsing disorder characterized by compulsive drug seeking and use despite adverse consequences.' These symptoms are not limited to drugs alone — they can apply to food, sex or even social media. Even though it's one of the most detrimental reasons, denying you have an addiction is not the only thing keeping you tied to your substance of choice. People with addictions tell themselves many things to make sure they never have to lose what they depend on most, and so they don't alarm those around them. Here are two lies that keep people with addictions trapped in harmful cycles of behavior. Unfortunately, most people will only believe they have a problem when they see the direct effects an addiction is having on their lives. If you are still making it to work appointments or making it in time to pick up the kids from school, it can be hard to see the impact your substance of choice has on your day-to-day life. A 'high-functioning' person with an addiction refers to someone who can maintain work, relationships and other responsibilities while still falling victim to their addictions. This perception of functionality makes them less likely to get help. According to a 2014 article in the Canadian Medical Association Journal (CMAJ), such individuals are at higher risk of being impacted by their addiction as people around them often do not intervene, likely because they do not recognize the issue at first. Dr. Steven Melemis, who specializes in addiction, tells CMAJ, 'The job is always the last thing that goes. A (person with an addiction) knows you need your job first and foremost to continue with your addiction.'a In such situations, rather than solely considering one's quality of life to understand the impact of addiction, it's important to reflect on your relationship to a particular substance. Are you unable to go one day without using it? Have you tried and failed in the past to put your addiction behind you? Do you have to work hard to fit your life around your addiction? These all could be signs that you may appear high-functioning, but are still someone that requires help. Hiding it better doesn't make it go away; it only delays the inevitable. Have you ever side-eyed the 10 am drinker even after you finished two bottles of wine the night before? Or perhaps you thanked your stars that you're not like that person at the party who gets blackout drunk everytime. Many people with addictions will compare themselves to others to prove that they're doing fine. However, just because you manage to control your impulses in specific situations or might even use substances from a place of privilege, it does not mean you aren't struggling with addiction. Addiction takes on various forms and can look different for different people. A 2024 survey from reports that at least 22% of 9-5 workers admit to using drugs or alcohol in the workplace. The survey also found that 16% of employees have noticed that one or more of their co-workers use illegal drugs or alcohol at work. However, these people are often dismissed as 'heavy drinkers,' or 'recreational users.' As long as they are contributing members of society, many people struggle to see themselves mirrored in the person with an addiction who has lost everything. This keeps them stuck in their own struggle. A 2011 study published in the International Journal of Environment Research and Public Health lists these behavioral patterns that can help identify if someone has an addiction: Admitting you have an addiction is never easy. Many people with addictions struggle with feelings of shame, feeling as though they have somehow failed in life or would be a burden if they asked for help. While the road to recovery is not linear, it's only possible through the acceptance of support and learning to have self-compassion. Self-awareness is a powerful first step to recovery, and it often starts with questioning our own mental defenses. Do you cope with life's challenges in healthy ways? Take this science-backed test to learn more: Coping Strategies Scale
Yahoo
3 days ago
- Yahoo
Entrada Therapeutics Appoints Maha Radhakrishnan, M.D., to its Board of Directors
Maha Radhakrishnan, MD BOSTON, June 03, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the appointment of Maha Radhakrishnan, M.D., to its Board of Directors. 'We are pleased to have Dr. Radhakrishnan join the Board at this time of tremendous clinical momentum at Entrada, led by the continued advancement of our Duchenne muscular dystrophy franchise. Dr. Radhakrishnan's deep and meaningful experience in global drug development will be invaluable as we quickly advance our novel Duchenne programs into multiple patient-focused clinical trials throughout this year,' said Dipal Doshi, Chief Executive Officer at Entrada Therapeutics. 'I'm honored to join the Board of Entrada as it advances its clinical-stage portfolio of Duchenne therapies and its growing pipeline of novel approaches for devastating diseases,' said Dr. Radhakrishnan. 'The promising Phase 1 safety and target engagement data, along with the urgent need for new treatments, reinforce the potential of Entrada's approach to change the lives of people living with Duchenne. I look forward to working with Dipal and the Board to help bring this new class of intracellular therapies to patients and families affected by Duchenne and other serious illnesses.' Since August 2024, Dr. Radhakrishnan has served as Executive Partner at Sofinnova Investments, a European venture capital firm focused on life sciences. At Sofinnova Investments, Dr. Radhakrishnan leads in-depth diligence across clinical-ready assets in multiple therapeutic areas and provides expertise to portfolio companies in areas including product development and commercialization. From January 2020 to March 2024, Dr. Radhakrishnan served as Group Senior Vice President and Chief Medical Officer at Biogen (NASDAQ: BIIB) where she was responsible for the worldwide medical function. Prior to Biogen, she served as Senior Vice President and Global Head of Medical, Primary Care Business Unit at Sanofi. Previously, she held several leadership roles at Bioverativ (acquired by Sanofi), Bristol Myers Squibb, UnitedHealth Group and Cephalon (acquired by Teva Pharmaceuticals). Dr. Radhakrishnan received her M.D. in Internal Medicine with honors from the People's Friendship University in Moscow, Russia, as well as a Master's degree in the Russian language. About Entrada TherapeuticsEntrada Therapeutics is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV™)-therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. The Company's lead oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. For more information about Entrada, please visit our website, and follow us on LinkedIn. Forward-Looking StatementsThis press release contains express and implied forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this press release, including statements regarding Entrada's strategy, future operations, prospects and plans, objectives of management, the validation and differentiation of Entrada's approach and EEV platform and its ability to provide a potential treatment for patients, and expectations regarding global Phase 2 clinical studies for ENTR-601-44, ENTR-601-45 and ENTR-601-50, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. The words 'anticipate,' 'believe,' 'continue,' 'could,' 'estimate,' 'expect,' 'intend,' 'may,' 'might,' 'objective,' 'ongoing,' 'plan,' 'predict,' 'project,' 'potential,' 'should,' or 'would,' or the negative of these terms, or other comparable terminology are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Entrada may not actually achieve the plans, intentions or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements as a result of various important factors, including the risks and uncertainties identified in Entrada's filings with the Securities and Exchange Commission (SEC), including the Company's most recent Form 10-K and in subsequent filings Entrada may make with the SEC. In addition, the forward-looking statements included in this press release represent Entrada's views as of the date of this press release. Entrada anticipates that subsequent events and developments will cause its views to change. However, while Entrada may elect to update these forward-looking statements at some point in the future, it specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Entrada's views as of any date subsequent to the date of this press release. Investor ContactKarla MacDonaldChief Corporate Affairs Officerkmacdonald@ Media ContactMegan Prock McGrathCTD Comms, LLCmegan@ A photo accompanying this announcement is available at in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
